Dr Morris was appointed as an Honorary Consultant and Senior Lecturer in Maternal and Fetal Medicine at the University of Birmingham (and Birmingham Women’s NHS Foundation Trust) in January 2015 and Reader in October 2018. In October 2020 she became Director of Birmingham Clinical Trials Unit.
She qualified from University of Liverpool in 1998 and then performed house jobs and specialist training within the East Midlands Deanery. In 2005 she came to Birmingham to commence her research and in 2008 commenced an MRC Clinical Research Training Fellowship. This led to the award of her PhD from the University of Birmingham in 2011.
Following her period in research, Dr Morris returned to clinical training as an NIHR Clinical Lecturer in Maternal Fetal medicine at the University of Birmingham/Birmingham Women’s Hospital NHS Foundation Trust. In 2014 she obtained her CCT in Obstetrics and Gynaecology and subspecialty accreditation in Maternal and Fetal Medicine from the Royal College of Obstetricians and Gynaecologists.
Her current role is as a member of a team of seven accredited consultant subspecialists providing regional and supra-regional care for pregnant women with fetal medicine problems at the West Midlands Fetal Medicine Centre which is situated within the Birmingham Women’s NHS Foundation Trust. Her clinical expertise relates to prenatal diagnosis, the diagnosis of fetal anomalies, conditions requiring fetal therapy including complications of monochorionic twins and intrauterine growth restriction and high risk obstetrics including maternal cardiac disease and preterm birth. Her research relates to her areas of clinical expertise and employs diverse methodologies including prognostic modelling, test accuracy research, epidemiology studies, randomised controlled trials, systematic reviews and meta-analyses. This research is funded from research councils and charities including MRC, HTA, RfPB, Wellbeing of Women, British Maternal and Fetal Medicine Society, Twins and Multiple Births Association, Mary Crosse Foundation and Richard and Jack Wiseman Trust.